Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes

被引:1
|
作者
Sun, Yikan [1 ,2 ,3 ,4 ]
Yinwang, Eloy [1 ,2 ,3 ,4 ]
Wang, Shengdong [1 ,2 ,3 ,4 ]
Wang, Zenan [1 ,2 ,3 ,4 ]
Wang, Fangqian [1 ,2 ,3 ,4 ]
Xue, Yucheng [1 ,2 ,3 ,4 ]
Zhang, Wenkan [1 ,2 ,3 ,4 ]
Zhao, Shenzhi [1 ,2 ,3 ,4 ]
Mou, Haochen [1 ,2 ,3 ,4 ]
Chen, Shixin [1 ,2 ,3 ,4 ]
Jin, Lingxiao [1 ,2 ,3 ,4 ]
Li, Binghao [1 ,2 ,3 ,4 ]
Ye, Zhaoming [1 ,2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Orthoped Res Inst, Hangzhou, Zhejiang, Peoples R China
[3] Key Lab Motor Syst Dis Res & Precis Therapy Zhejia, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Univ, Affiliated Hosp 2, Musculoskeletal Tumor Ctr, Sch Med,Dept Orthoped, Hangzhou 310009, Peoples R China
基金
中国国家自然科学基金;
关键词
CD8(+) T cells; Tumour-infiltrating lymphocytes; T cell nomenclature; T cell exclusion; Caner immunotypes; Cancer immunotherapy; CANCER-ASSOCIATED FIBROBLASTS; T-CELL DYSFUNCTION; MEMORY STEM-CELLS; RESIDENT MEMORY; DENDRITIC CELLS; B-CELLS; PREFERENTIAL LOCALIZATION; VIRAL-INFECTION; LOCAL IMMUNITY; PD-L1; BLOCKADE;
D O I
10.1186/s12943-024-02104-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD8(+) T cells are the workhorses executing adaptive anti-tumour response, and targets of various cancer immunotherapies. Latest advances have unearthed the sheer heterogeneity of CD8(+) tumour infiltrating lymphocytes, and made it increasingly clear that the bulk of the endogenous and therapeutically induced tumour-suppressive momentum hinges on a particular selection of CD8(+) T cells with advantageous attributes, namely the memory and stem-like exhausted subsets. A scrutiny of the contemporary perception of CD8(+) T cells in cancer and the subgroups of interest along with the factors arbitrating their infiltration contextures, presented herein, may serve as the groundwork for future endeavours to probe further into the regulatory networks underlying their differentiation and migration, and optimise T cell-based immunotherapies accordingly.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Tumour-infiltrating CD4 and CD8 T lymphocytes in breast cancer
    Gisterek, Iwona
    Frydecka, Irena
    Swiatoniowski, Grzegorz
    Fidler, Sebastian
    Kornafel, Jan
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2008, 13 (04) : 206 - 209
  • [22] Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma
    Ramzan, Muhammad
    Sturm, Nathalie
    Decaens, Thomas
    Bioulac-Sage, Paulette
    Bancel, Brigitte
    Merle, Philippe
    Jeanne Tran Van Nhieu
    Slama, Remy
    Letoublon, Christian
    Zarski, Jean-Pierre
    Jouvin-Marche, Evelyne
    Marche, Patrice N.
    Leroy, Vincent
    LIVER INTERNATIONAL, 2016, 36 (03) : 434 - 444
  • [23] The Heterogeneity of Tumour Infiltrating Lymphocytes and its Effect on Patient Outcome
    Althobiti, M.
    Aleskandarany, M. A.
    Green, A. R.
    Joseph, C.
    Rodriguez, M. Diez
    Nolan, C. C.
    Ellis, I. O.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2017, 243 : S17 - S17
  • [24] Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
    A N Seo
    H J Lee
    E J Kim
    H J Kim
    M H Jang
    H E Lee
    Y J Kim
    J H Kim
    S Y Park
    British Journal of Cancer, 2013, 109 : 2705 - 2713
  • [25] CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma
    Nordfors, Cecilia
    Grun, Nathalie
    Tertipis, Nikolaos
    Ahrlund-Richter, Andreas
    Haeggblom, Linnea
    Sivars, Lars
    Du, Juan
    Nyberg, Tommy
    Marklund, Linda
    Munck-Wikland, Eva
    Nasman, Anders
    Ramqvist, Torbjorn
    Dalianis, Tina
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (11) : 2522 - 2530
  • [26] Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
    Sato, E
    Olson, SH
    Ahn, J
    Bundy, B
    Nishikawa, H
    Qian, F
    Jungbluth, AA
    Frosina, D
    Gnjatic, S
    Ambrosone, C
    Kepner, J
    Odunsi, T
    Ritter, G
    Lele, S
    Chen, YT
    Ohtani, H
    Old, LJ
    Odunsi, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) : 18538 - 18543
  • [27] Prognostic value of CD8+tumour infiltrating lymphocytes (TILs) in male breast cancer
    Bettaieb, I.
    Abdeljaoued, S.
    Chiba, D.
    Adouni, O.
    Nasri, M.
    Goucha, A.
    Tekari, F.
    Rahal, K.
    Gamoudi, A.
    VIRCHOWS ARCHIV, 2017, 471 : S53 - S53
  • [28] Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells
    Catalina, MD
    Sullivan, JL
    Brody, RM
    Luzuriaga, K
    JOURNAL OF IMMUNOLOGY, 2002, 168 (08): : 4184 - 4191
  • [29] CHARACTERIZATION OF THE CD4+ AND CD8+ TUMOR INFILTRATING LYMPHOCYTES PROPAGATED WITH BISPECIFIC MONOCLONAL-ANTIBODIES
    WONG, JT
    PINTO, CE
    GIFFORD, JD
    KURNICK, JT
    KRADIN, RL
    JOURNAL OF IMMUNOLOGY, 1989, 143 (10): : 3404 - 3411
  • [30] Divide and Conquer: Phenotypic and Temporal Heterogeneity Within CD8+ T Cell Responses
    Richard, Arianne C.
    FRONTIERS IN IMMUNOLOGY, 2022, 13